HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION

HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION

Dades bibliogràfiques
Autors principals:	Macmahon, S, Collins, R, Flather, M, Knight, C, Remvig, L, Mortensen, S, Godwin, J, Yusuf, S, Peto, R
Format:	Journal article
Publicat:	1992

Ítems similars

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
per: Collins, R, et al.
Publicat: (1996)

REDUCTION IN MAJOR MORBIDITY AND MORTALITY BY HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
per: Macmahon, S, et al.
Publicat: (1989)

GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?
per: Collins, R, et al.
Publicat: (1990)

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
per: Yusuf, S, et al.
Publicat: (1988)

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials.
per: MacMahon, S, et al.
Publicat: (1988)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
per: Collins, R, et al.
Publicat: (1997)

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
per: Latini, R, et al.
Publicat: (2000)

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
per: Latini, R, et al.
Publicat: (2000)

Beta blockade during and after myocardial infarction: an overview of the randomized trials.
per: Yusuf, S, et al.
Publicat: (1985)

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin - Systematic overview of individual data from 96,712 randomized patients
per: Latini, R, et al.
Publicat: (2000)

Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
per: Mahaffey, K, et al.
Publicat: (1996)

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.
per: Teo, K, et al.
Publicat: (1991)

REDUCTION IN MORTALITY AFTER MYOCARDIAL-INFARCTION BY ACUTE INTERVENTION
per: Yusuf, S, et al.
Publicat: (1983)

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
per: Altman, R, et al.
Publicat: (1994)

Magnesium in acute myocardial infarction.
per: Collins, R, et al.
Publicat: (1997)

Magnesium theory in acute myocardial infarction.
per: Collins, R, et al.
Publicat: (1996)

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
per: Collins, R, et al.
Publicat: (1988)

Film Properties of Heparin Cross-Linked with Epichlorohydrin in Absence or Presence of Imidazole
per: Ivan Šimkovic, et al.
Publicat: (2024-11-01)

EXERCISE AFTER MYOCARDIAL-INFARCTION REDUCES MORTALITY - EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS (RCTS)
per: Collins, R, et al.
Publicat: (1984)

OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION
per: Sleight, P, et al.
Publicat: (1986)

RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
per: Collins, R, et al.
Publicat: (1987)

RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
per: Collins, R
Publicat: (1987)

Antiplatelet therapies: An overview
per: Gundu H R Rao
Publicat: (2016-01-01)

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.
per: Yusuf, S, et al.
Publicat: (1985)

Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
per: Sophia Khattak, et al.
Publicat: (2024-03-01)

ANTIPLATELET THERAPY TO PREVENT THROMBOSIS AFTER HIP FRACTURE - REPLY
per: Macmahon, S, et al.
Publicat: (1995)

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
per: I. S. Yavelov
Publicat: (2009-12-01)

Management of the heparin induced thrombocytopenia in the course of acute myocardial infarction
per: Ali Çoner, et al.
Publicat: (2020-07-01)

Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
per: Collins, R
Publicat: (1987)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
per: Collins, R, et al.
Publicat: (1994)

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE
per: R. D. Kurbanov, et al.
Publicat: (2015-09-01)

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE
per: R. D. Kurbanov, et al.
Publicat: (2015-09-01)

TRIALS OF ANTIPLATELET THERAPY - REPLY
per: Baigent, C, et al.
Publicat: (1994)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
per: Collins, R, et al.
Publicat: (1997)

Heparin induced thrombocytopenia type ii and myocardial infarction: Two case reports
per: Antonijević Nebojša, et al.
Publicat: (2004-01-01)

INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
per: Stampfer, M, et al.
Publicat: (1983)

Clopidogrel and metoprolol in myocardial infarction - Reply
per: Chen, Z, et al.
Publicat: (2006)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
per: Ting-Tse Lin, et al.
Publicat: (2018-04-01)

Antiplatelet agents: an overview
per: Asma Haffouz, et al.
Publicat: (2023-01-01)

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction.
per: Zahra Lotfollahi, et al.
Publicat: (2022-01-01)